Moleculin Biotech, Inc. (MBRX)

NASDAQ: MBRX · IEX Real-Time Price · USD
+0.019 (3.13%)
At close: Feb 29, 2024, 4:00 PM
+0.048 (7.68%)
After-hours: Feb 29, 2024, 4:15 PM EST

Total Valuation

MBRX has a market cap or net worth of $20.62 million. The enterprise value is -$3.47 million.

Market Cap 20.62M
Enterprise Value -3.47M

Important Dates

The next estimated earnings date is Wednesday, March 20, 2024, after market close.

Earnings Date Mar 20, 2024
Ex-Dividend Date n/a

Share Statistics

MBRX has 33.41 million shares outstanding. The number of shares has increased by 4.13% in one year.

Shares Outstanding 33.41M
Shares Change (YoY) +4.13%
Shares Change (QoQ) +0.41%
Owned by Insiders (%) 4.65%
Owned by Institutions (%) 15.54%
Float 25.77M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.59
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.10, with a Debt / Equity ratio of 0.01.

Current Ratio 7.10
Quick Ratio n/a
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -60.60% and return on invested capital (ROIC) is -77.90%.

Return on Equity (ROE) -60.60%
Return on Assets (ROA) -53.90%
Return on Capital (ROIC) -77.90%
Revenue Per Employee n/a
Profits Per Employee -$1.75M
Employee Count 15
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -49.60% in the last 52 weeks. The beta is 1.93, so MBRX's price volatility has been higher than the market average.

Beta (1Y) 1.93
52-Week Price Change -49.60%
50-Day Moving Average 0.61
200-Day Moving Average 0.57
Relative Strength Index (RSI) 62.55
Average Volume (30 Days) 166,045

Short Selling Information

The latest short interest is 137,674, so 0.41% of the outstanding shares have been sold short.

Short Interest 137,674
Short Previous Month 219,995
Short % of Shares Out 0.41%
Short % of Float 0.53%
Short Ratio (days to cover) 1.02

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -27.76M
Pretax Income -26.27M
Net Income -26.27M
EBITDA -26.15M
EBIT -26.27M
Earnings Per Share (EPS) -$0.90
Full Income Statement

Balance Sheet

The company has $24.58 million in cash and $496,000 in debt, giving a net cash position of $24.08 million or $0.72 per share.

Cash & Cash Equivalents 24.58M
Total Debt 496,000
Net Cash 24.08M
Net Cash Per Share $0.72
Equity / Book Value 35.14M
Book Value Per Share 1.05
Working Capital 23.72M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$25.95 million and capital expenditures -$43,000, giving a free cash flow of -$25.99 million.

Operating Cash Flow -25.95M
Capital Expenditures -43,000
Free Cash Flow -25.99M
FCF Per Share -$0.87
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MBRX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -4.13%
Shareholder Yield -4.13%
Earnings Yield -127.43%
FCF Yield -126.08%

Analyst Forecast

The average price target for MBRX is $8.00, which is 1,171.86% higher than the current price. The consensus rating is "Strong Buy".

Price Target $8.00
Price Target Difference 1,171.86%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on February 1, 2021. It was a reverse split with a ratio of 1:6.

Last Split Date Feb 1, 2021
Split Type Reverse
Split Ratio 1:6


Altman Z-Score n/a
Piotroski F-Score 1